GCAP2 Antibodies

Santa Cruz Biotechnology delivers a wide array of GCAP2 monoclonal antibodies for research focused on guanylate cyclase-activating protein 2 (GCAP2). GCAP2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GCAP2 is a calcium-binding protein that plays a crucial role in the regulation of phototransduction in retinal photoreceptors. By modulating the activity of guanylate cyclase, GCAP2 is essential for maintaining the balance of cyclic GMP levels, which is vital for normal visual function. Dysregulation of GCAP2 has been implicated in various retinal diseases, making it a significant target for both basic research and potential therapeutic applications. Understanding GCAP2's molecular mechanisms and interactions can provide valuable insights into retinal function and disease progression. Research utilizing GCAP2 monoclonal antibodies continues to advance our knowledge of visual processing pathways. Investigating GCAP2's role in calcium signaling pathways has revealed important aspects of photoreceptor cell biology. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing vision science and developing potential treatments for retinal disorders.